Hematological Disease
Coagulation System
JOINN has established a relatively complete coagulation system efficacy screening model, which can evaluate the efficacy of pro-coagulation drugs such as factor VIII, factor VII, factor X activator, and anti-coagulation drugs such as heparin, factor X inhibitors, and factor II inhibitors.Established efficacy evaluation models are as follows:
Anticoagulant drugs
mouse model of tail hemorrhage
mouse model of hemophilia
Procoagulant drugs
Rat model of thrombosis caused by inferior vena cava stenosis
Rat inferior vena cava congestion induced thrombosis model
Rat model of thrombosis induced by arteriovenous bypass silk thread
Share